The entire pain management therapeutics market has been sub-categorized into therapeutics and indication. This section covers regional segmentation which accentuates on current and future demand for pain management therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Growing chronic or acute pains among the global population due to low lifestyles, underlying health conditions, or surgical procedures will be the leading trends propelling the market forward. Increased incidence of pain due to accident and sports injuries and the adoption of pain medications for faster relief will boost market growth. The rising geriatric population and high rates of cancer worldwide will be a market booster. The upsurge in the number of people suffering from lower back problems, especially among working individuals that can negatively impact productivity, their financial and emotional state will escalate market growth. The roadblocks to the development of this market are lack of awareness and stringent government regulations.
By Therapeutics
- Anticonvulsants
- Antidepressants
- Anesthetics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDS)
- Opioids
- Antimigraine Agents
- Other Non-Narcotic Analgesic
By Indication
- Neuropathic Pain
- Fibromyalgia
- Chronic Back Pain
- Arthritic Pain
- Migraine
- Post-Operative Pain
- Cancer Pain
The major players in the pain management therapeutics market include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc.
Source: https://www.valuemarketresearch.com/report/pain-management-therapeutics-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.